Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 13/20 | 0.50 |
| ▸ | ACACA | Q13085 | 13/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL879062 | 1.00 | ACACB (0.50) | ACACBACACACHRM2CHRM4CHRM5 | |
| SCHEMBL2850592 | 0.85 | ACACB (0.52) | ACACBACACACHRM2CHRM4CHRM5 | |
| SCHEMBL11932139 | 0.84 | ACACB (0.52) | ACACBACACACHRM2CHRM4CHRM5 | |
| SCHEMBL2850600 | 0.84 | ACACB (0.54) | ACACBACACACHRM2CHRM4CHRM5 | |
| SCHEMBL2850595 | 0.84 | ACACB (0.54) | ACACBACACACHRM2CHRM4CHRM5 | |
| SCHEMBL12778736 | 0.84 | ACACB (0.52) | ACACBACACACHRM2CHRM4CHRM5 | |
| SCHEMBL13527319 | 0.83 | ACACB (0.51) | ACACBACACACHRM2CHRM4CHRM5 | |
| SCHEMBL18393305 | 0.83 | ACACB (0.51) | ACACBACACACHRM2CHRM4CHRM5 | |
| SCHEMBL15894937 | 0.83 | ACACB (0.51) | ACACBACACACHRM2CHRM4CHRM5 | |
| SCHEMBL30057496 | 0.82 | ACACB (0.70) | ACACBACACACHRM2CHRM4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120178786-A9 | Use of tetramic acid derivatives for controlling pests by drenching, drip application, or dip application | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2012-07-12 | — | — | US | disclosed |
| US-20090099247-A1 | Use of tetramic acid derivatives for controlling pets by drenching, drip application, dip application or soil injection | BAYER CROPSCIENCE AG (DE) | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178786-A9 | Use of tetramic acid derivatives for controlling pests by drenching, drip application, or dip application | DDT, DAO, TREH | ACACB 1387/4885ACACA 1679/4885CHRM2 932/4885 |
| US-20090099247-A1 | Use of tetramic acid derivatives for controlling pets by drenching, drip application, dip application or soil injection | DDT, DAO, NPY5R | ACACB 1480/4885ACACA 1423/4885CHRM2 989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.